---
input_text: 'Apert syndrome and sleep apnea. '
raw_completion_output: |-
  primary_disease: Apert syndrome

  medical_actions: 

  symptoms: sleep apnea

  chemicals: 

  action_annotation_relationships: 
prompt: |+
  Split the following piece of text into fields in the following format:

  primary_disease: <The main disease the text is about, or its central disease topic. This is often the disease mentioned in an article's title or in its first few sentences.>
  medical_actions: <Semicolon-separated list of medical actions, where each is a clinically prescribed procedure, therapy, intervention, or recommendation.>
  symptoms: <Semicolon-separated list of signs or symptoms.>
  chemicals: <Semicolon-separated list of chemicals or drugs>
  action_annotation_relationships: <Semicolon-separated list of relationships between a disease, the mentioned signs and symptoms associated with that disease, the medical actions relating to each symptom, and the type of relationship between each action and symptom (usually TREATS or PREVENTS). The disease name must be included in the relationship, for example, "treatment TREATS symptom IN disease". If the medical action includes a specific chemical or drug, include the chemical or drug name in the relationship, for example, "treatment (with chemical) TREATS symptom IN disease".>


  Text:
  Apert syndrome and sleep apnea. 

  ===

extracted_object:
  primary_disease: MONDO:0007041
  symptoms:
    - HP:0010535
named_entities:
  - id: MONDO:0007041
    label: Apert syndrome
  - id: MAXO:0000486
    label: Distraction osteogenesis
  - id: HP:0012531
    label: Pain
  - id: HP:0001288
    label: Gait disturbances
  - id: HP:0001159
    label: Syndactyly
  - id: HP:0001363
    label: craniosynostosis
  - id: HP:0011800
    label: midface hypoplasia
  - id: MONDO:0015338
    label: syndromic craniosynostosis
  - id: HP:0001061
    label: Acne
  - id: CHEBI:6067
    label: Isotretinoin
  - id: MONDO:0015469
    label: Craniosynostosis
  - id: HP:0000504
    label: Vision issues
  - id: HP:0000572
    label: Visual loss
  - id: HP:0000646
    label: Amblyopia
  - id: HP:0001138
    label: Optic neuropathy
  - id: HP:0000486
    label: Strabismus
  - id: HP:0012803
    label: Anisometropia
  - id: HP:0000483
    label: Astigmatism
  - id: MAXO:0000502
    label: tracheal intubation
  - id: HP:0009102
    label: Anterior open bite
  - id: MAXO:0001183
    label: Bronchoscopy
  - id: MAXO:0000504
    label: Tracheotomy
  - id: MAXO:0001029
    label: Adenoidectomy
  - id: MAXO:0001081
    label: Tonsillectomy
  - id: HP:0002104
    label: Apneic episodes
  - id: HP:0002098
    label: Respiratory distress
  - id: HP:0010307
    label: Stridor
  - id: HP:0000961
    label: Cyanosis
  - id: HP:0000689
    label: malocclusion
  - id: HP:0002902
    label: Hyponatremia
  - id: MAXO:0010031
    label: bone grafting
  - id: MAXO:0001291
    label: cranioplasty
  - id: HP:0001249
    label: mental retardation
  - id: HP:0001263
    label: developmental delays
  - id: HP:0002516
    label: raised intracranial pressure
  - id: HP:0010535
    label: sleep apnea
  - id: HP:0000174
    label: palatal anomalies
  - id: HP:0000175
    label: Cleft palate
  - id: HP:0000365
    label: Hearing loss
  - id: HP:0003298
    label: Spina bifida occulta
  - id: HP:0001627
    label: Cardiac anomalies
  - id: HP:0001818
    label: Paronychia
  - id: MAXO:0000506
    label: Noninvasive ventilation
  - id: HP:0002870
    label: Obstructive apneas
  - id: HP:0000453
    label: Choanal atresia
  - id: HP:0004411
    label: Deviated nasal septum
  - id: HP:0002871
    label: Central apneas
  - id: HP:0002308
    label: Chiari malformations
  - id: MONDO:0002457
    label: Tracheal Cartilaginous Sleeve (TCS) in Syndromic Craniosynostosis
  - id: MAXO:0001189
    label: Laryngoscopy
  - id: HP:0002119
    label: Enlarged cerebral ventricles
  - id: HP:0005347
    label: Tracheal Cartilaginous Sleeve
  - id: MAXO:0000647
    label: Chemotherapy
  - id: MAXO:0000014
    label: Radiotherapy
  - id: CHEBI:22333
    label: Alkylating agents
